69
49
Growth Score 69 in past quarter
-3 pts
Heat Score 49 in past quarter
-35 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Biovance Capital is a new € 60M fund to invest in early-stage biotech companies across Europe.
- Ricardo Perdigão Henriques: Managing PartnerPast Role: Bionova Capital, CEO
- Joao Incio: General Partner
About the Company
Biovance Capital is a new € 51M fund to invest in early-stage biotech companies across Europe developing innovative therapeutics in all disease areas and drug modalities (small and large molecules, vaccines, cell, and gene therapies).